Considerably higher values of this marker (compared to the control group) were observed in both the diet-treated subgroup (GDM 1: 8.40 vs. 4.79 ng/mL) and the insulin therapy group (GDM 2: 10.96 vs. 4.79 ng/mL) (p = 0.0178). Here, INS is linked to gestational diabetes.